Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...

The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

Anyone discouraged by the continued absence of a prostate cancer screening programme, the difficulties in getting a clear ...

The known prostate cancer drug, Abiraterone, will be accessible for patients in the coming week, after a campaign led by a ...

In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...

Up to 85 percent of prostate cancers are diagnosed in the early stages, when they are still curable.Even when diagnosed at an advanced stage, most prostate cancers respond well to treatment. The first ...

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...